Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
Conclusions: Adiponectin is not dysregulated in SMI but is associated with CVD risk regardless of AP treatment regime.
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
More News: Bipolar | Cardiology | Cardiovascular | Cholesterol | Eating Disorders & Weight Management | Heart | Mania | Men | Obesity | Psychiatry | Schizophrenia | Seroquel | Zyprexa